SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,819 | +138.2% | 81 | +125.0% | 0.00% | – |
| Q2 2023 | $4,123 | -32.0% | 36 | -18.2% | 0.00% | – |
| Q1 2023 | $6,065 | +73.3% | 44 | +63.0% | 0.00% | – |
| Q4 2022 | $3,499 | +16.6% | 27 | -10.0% | 0.00% | – |
| Q3 2022 | $3,000 | – | 30 | +400.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 6 | -96.5% | 0.00% | – |
| Q1 2022 | $13,000 | -78.0% | 171 | -73.0% | 0.00% | -100.0% |
| Q3 2021 | $59,000 | +51.3% | 634 | +27.1% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -25.0% | 499 | -28.6% | 0.00% | 0.0% |
| Q1 2021 | $52,000 | -56.3% | 699 | 0.0% | 0.00% | -66.7% |
| Q4 2020 | $119,000 | +21.4% | 699 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $98,000 | -12.5% | 699 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $112,000 | +64.7% | 699 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $68,000 | -24.4% | 699 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $90,000 | +69.8% | 699 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $53,000 | -50.0% | 699 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $106,000 | +27.7% | 699 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $83,000 | +9.2% | 699 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $76,000 | -32.7% | 699 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $113,000 | +22.8% | 699 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $92,000 | +76.9% | 699 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $52,000 | +33.3% | 699 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $39,000 | +21.9% | 699 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $32,000 | +146.2% | 699 | +75.2% | 0.00% | +200.0% |
| Q2 2017 | $13,000 | +8.3% | 399 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $12,000 | +9.1% | 399 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $11,000 | -56.0% | 399 | 0.0% | 0.00% | -66.7% |
| Q3 2016 | $25,000 | +212.5% | 399 | 0.0% | 0.00% | +200.0% |
| Q2 2016 | $8,000 | 0.0% | 399 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | -46.7% | 399 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $15,000 | +15.4% | 399 | 0.0% | 0.00% | -40.0% |
| Q3 2015 | $13,000 | +8.3% | 399 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $12,000 | +140.0% | 399 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $5,000 | – | 399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |